This is a StreetInsider.com Premium Only Page

Jazz Pharmaceuticals (JAZZ) – StreetInsider.com Reports

Apr 2, 2024 07:32 AM Jazz Pharmaceuticals (JAZZ) Completes Zanidatamab BLA for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer

Mar 25, 2024 08:48 AM Jazz Pharmaceuticals (JAZZ) PT Raised to $190 at JPMorgan

Mar 20, 2024 06:55 AM Jazz Pharmaceuticals (JAZZ) PT Raised to $188 at Piper Sandler

Mar 15, 2024 07:58 AM Jazz Pharmaceuticals (JAZZ) PT Raised to $230 at Stifel

Mar 14, 2024 06:36 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $200 at H.C. Wainwright

Mar 1, 2024 08:17 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $131 at UBS

Mar 1, 2024 02:38 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $230 at Barclays

Feb 29, 2024 07:50 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $220 at Needham

Feb 29, 2024 07:24 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $170 at JPMorgan

Feb 28, 2024 04:16 PM Jazz Pharmaceuticals (JAZZ) Misses Q4 EPS by 16c; offers guidance

Feb 27, 2024 07:57 AM Jazz Pharmaceuticals (JAZZ) Appoinys Patrick Kennedy to its Board

Feb 21, 2024 07:46 AM Jazz Pharmaceuticals (JAZZ) names Philip Johnson CFO

Feb 7, 2024 05:33 AM Jazz Pharmaceuticals (JAZZ) to Acquire Global Rights to KRAS Inhibitor Program from Redx Pharma

Jan 29, 2024 04:16 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $235 at Barclays

Jan 23, 2024 05:47 AM Apple (AAPL) Added to BofA US 1 List, Jazz Pharmaceuticals (JAZZ) Removed

Jan 3, 2024 07:19 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $171 at Piper Sandler

Jan 3, 2024 04:22 AM Baird Starts Jazz Pharmaceuticals (JAZZ) at Outperform

Dec 21, 2023 04:40 PM Jazz Pharmaceuticals drops 4% as study of PTSD misses primary endpoint

Dec 21, 2023 04:14 PM Jazz Pharmaceuticals (JAZZ) Declined 4% After Phase 2 Trial of JZP150 in PTSD Fails

Dec 21, 2023 04:05 PM Jazz Pharmaceuticals (JAZZ) Reports Phase 2 Trial of JZP150 Did Not Meet Endpoints

Dec 15, 2023 07:49 AM Jazz Pharmaceuticals (JAZZ) Announces Departure of EVP and General Manager Kim Sablich

Nov 29, 2023 07:49 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $155 at Jefferies

Nov 27, 2023 11:21 AM Teva Pharma 'uniquely positioned,' Jazz Pharmaceuticals set-up balanced - UBS

Nov 27, 2023 04:08 AM UBS Downgrades Jazz Pharmaceuticals (JAZZ) to Neutral, 'Balanced risk/reward'

Nov 14, 2023 03:49 AM Jazz Pharmaceuticals (JAZZ) and Autifony Enter Exclusive Global License and Collaboration Agreement on Two Ion Channel Targets for Neurological Disorders

Nov 9, 2023 07:17 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $225 at Needham & Company

Nov 9, 2023 06:43 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $191 at RBC Capital

Nov 8, 2023 04:40 PM Jazz Pharmaceuticals (JAZZ) Misses Q3 EPS by 9c; Offers FY23 EPS Guidance

Nov 7, 2023 07:46 AM Jazz Pharmaceuticals (JAZZ) and MD Anderson Announce Five-Year Collaboration to Evaluate Zanidatamab in HER2-Expressing Cancers

Oct 20, 2023 08:00 AM Jazz Pharmaceuticals (JAZZ) gains on potenital sale, analyst says break-up 'makes sense'

Oct 19, 2023 10:22 PM Jazz Pharmaceuticals (JAZZ) Is Said To Explore Options Including Sale - Bloomberg

Oct 3, 2023 09:05 AM Disney, Boeing and other stocks to avoid due to tax loss selling

Sep 28, 2023 04:27 PM Raymond James Starts Jazz Pharmaceuticals (JAZZ) at Market Perform

Sep 21, 2023 05:42 PM Jazz Pharmaceuticals (JAZZ) Granted EU Approval for Enrylaze

Sep 12, 2023 07:33 AM Jazz Pharmaceuticals (JAZZ) CFO Promoted to President and COO

Aug 14, 2023 06:32 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $180 at Cantor Fitzgerald

Aug 10, 2023 06:12 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $201 at RBC Capital

Aug 9, 2023 04:11 PM Jazz Pharmaceuticals (JAZZ) Tops Q2 EPS by 6c, beats revenue

Jul 21, 2023 08:09 AM Jazz Pharmaceuticals (JAZZ) Receives CHMP Positive Opinion for JZP458

Jun 12, 2023 05:11 AM Wells Fargo Assumes Jazz Pharmaceuticals (JAZZ) at Equal Weight

Jun 5, 2023 05:53 AM Jazz Pharmaceuticals (JAZZ) and Zymeworks (ZYME) Present Positive Pivotal Phase 2b Trial Data

May 11, 2023 07:19 AM Jazz Pharmaceuticals (JAZZ) PT Raised to $212 at Needham & Company

May 11, 2023 06:39 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $202 at RBC Capital

May 10, 2023 04:11 PM Jazz Pharmaceuticals (JAZZ) Misses Q1 EPS by 29c; offers guidance

Mar 3, 2023 06:15 AM Jazz Pharmaceuticals (JAZZ) PT Raised to $212 at Goldman Sachs

Mar 2, 2023 07:37 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $205 at Needham & Company

Mar 2, 2023 06:01 AM Jazz Pharmaceuticals (JAZZ) PT Raised to $212 at Goldman Sachs

Mar 1, 2023 04:16 PM Jazz Pharmaceuticals (JAZZ) Misses Q4 EPS by Wide Margin; Guides FY23

Jan 27, 2023 06:36 AM Jazz Pharmaceuticals (JAZZ) PT Raised to $192 at UBS

Jan 19, 2023 07:46 AM Jazz Pharmaceuticals (JAZZ), Zymeworks (ZYME) Announce 84% OS at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal Adenocarcinoma